Xenetic Biosciences Revenue, Profits - XBIO Quarterly Income Statement

Add to My Stocks
$2.41 $0.17 (6.59%) XBIO stock closing price Sep 18, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Xenetic Biosciences stock price. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the XBIO stock is bound to reflect the impact of the QOQ decline of 0. Revenue for year 2018 Q2 is $- and has decreased from $- quarter on quarter as is evident when you compare the latest figures in the latest Xenetic Biosciences profit and loss statement with those of the prior corresponding period. Also see Xenetic Biosciences assets and Xenetic Biosciences free cash flow for a complete valuation of XBIO stock.

View and download details of revenue and profits for Xenetic Biosciences for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Xenetic Biosciences Revenues or Net Sales
Cost Of Goods Sold (COGS)----------
Xenetic Biosciences Gross Profit
Research & Development Expense--1.08M--1.22M--41.7M-
Selling General & Admin Expense1.07M1.12M1.99M1.34M1.97M1.63M2.37M1.35M1.55M1.42M
Income Before Depreciation Depletion Amortization-1.99M-1.82M4.43M-2.24M-2.9M-2.85M-0.07M-2.25M-43.26M-1.85M
Depreciation Depletion Amortization----------
Non Operating Income-0.03M---0.01M-0.01M-0.01M-0.29M--4.4M-1.47M
Interest Expense----------
Xenetic Biosciences Pretax Income
Provision for Income Taxes----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-2.03M-1.82M4.43M-2.26M-2.92M-2.87M-0.39M-2.47M-47.77M-3.57M
Extraordinary Items & Discontinued Operations----------
Xenetic Biosciences Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS-8.72M-8.72M8.71M8.52M7.28M8.99M7.8M4.59M
Average Shares used to compute Basic EPS-8.72M-8.72M8.71M8.52M7.28M8.99M7.8M4.59M
Income Before Nonrecurring Items--1.82M--2.26M-2.92M-2.87M-0.16M-2.47M-43.35M-3.57M
Income from Nonrecurring Items-------0.23M--4.42M-
Xenetic Biosciences Earnings Per Share Basic Net
Xenetic Biosciences Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items--0.21--0.26-0.34-0.34-0.28-0.28-5.55-0.66
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our PHI Inc financial analysis

Xenetic Biosciences stock analysis involves checking at least a few of the important things like:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Xenetic Biosciences revenue chart, implies that the company is growing. It has not been the case with Xenetic Biosciences. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. XBIO stock had a poor bottom line growth.

The income statement is also called the profit and loss statement. Apart from the XBIO income statement, one can check the Xenetic Biosciences historical stock prices to check how the price has moved with time.

Xenetic Biosciences Income Statement - Key Financial Ratios